GlassScriptPhysician profile
Scott C Stoioff
NPI 1881763316
$7,489.60
in general payments reported to CMS, 2019-2025
34 companies · $1,522 in 2025
The $1,522 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,781 · 2020: $733 · 2021: $1,416 · 2022: $759 · 2023: $458 · 2024: $821 · 2025: $1,522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,800.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,307.19 | 2021-2025 | Urolift, Barrigel |
| Dendreon Pharmaceuticals LLC | $1,054.70 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $816.98 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Astellas Pharma US INC | $710.21 | 2019-2025 | Xtandi |
| Neotract INC. | $483.93 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $318.95 | 2019-2024 | Xiaflex, Aveed |
| Antares Pharma, INC. | $297.59 | 2019-2025 | Xyosted |
| Bayer Healthcare Pharmaceuticals INC. | $292.80 | 2019-2025 | |
| Pfizer INC. | $268.76 | 2019-2025 | |
| Coloplast Corp | $256.50 | 2019-2025 | Isiris Astent Removal Device |
| Boston Scientific Corporation | $242.89 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $187.01 | 2024-2025 | Orgovyx, Gemtesa |
| Myovant Sciences INC. | $157.35 | 2021-2022 | |
| Endo USA, INC. | $155.99 | 2024-2025 | Aveed, Xiaflex |
| Abbvie INC. | $142.72 | 2019-2025 | Botox |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $87.01 | 2025 | Trelstar, Tlando |
| Merck Sharp & Dohme LLC | $72.62 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Urovant Sciences INC | $71.15 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $67.35 | 2020-2025 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
| Zyla Life Sciences, INC. | $62.90 | 2019-2020 | |
| Allergan, INC. | $53.87 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $50.68 | 2019 | |
| Clarus Therapeutics INC. | $44.75 | 2021 | |
| Aytu Biopharma, INC. | $42.21 | 2019 | |
| Tolmar, INC. | $39.93 | 2024 | |
| 180 Medical, INC. | $36.05 | 2019 | |
| Photocure INC | $34.14 | 2024-2025 | Cysview |
| Calyxo, INC. | $30.39 | 2024 | Cvac Aspiration System |
| Urogen Pharma, INC. | $22.73 | 2025 | |
| Dornier Medtech America, INC | $17.68 | 2019 | |
| Caris Mpi, INC. | $16.94 | 2025 | Mi Cancer Seek |
| Tolmar Pharmaceuticals, INC. | $16.65 | 2020 | |
| Avadel Specialty Pharmaceuticals, LLC | $15.45 | 2019 | |
| Halozyme INC | $13.53 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Stoioff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.